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Abstract
In yeast, DNA polymerase zeta (Rev3 and Rev7) and Rev1, involved in the error-prone translesion synthesis during
replication of nuclear DNA, localize also in mitochondria. We show that overexpression of Rev3 reduced the mtDNA
extended mutability caused by a subclass of pathological mutations in Mip1, the yeast mitochondrial DNA polymerase
orthologous to human Pol gamma. This beneficial effect was synergistic with the effect achieved by increasing the dNTPs
pools. Since overexpression of Rev3 is detrimental for nuclear DNA mutability, we constructed a mutant Rev3 isoform
unable to migrate into the nucleus: its overexpression reduced mtDNA mutability without increasing the nuclear one.
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Introduction
In yeast, DNA polymerase zeta (Pol zeta) and Rev1 are involved
in the error-prone translesion synthesis (TLS) during replication of
nuclear DNA: mutations in any of these polymerases lead to a
decrease of mutagenesis in nuclear genome either in normal
conditions or in conditions known to increase DNA damage such
as UV treatment [1]. The yeast Pol zeta is composed by a catalytic
subunit encoded by REV3 and an accessory subunit encoded by
REV7. Biochemically, Pol zeta is a poorly processive enzyme [2],
lacks of a 39-59 exonucleolytic proofreading activity [3] and is able
to extend terminally mismatched primers [4–6]. From these
properties derives its propensity to generate mutations. On the
contrary, Pol zeta is very inefficient in inserting nucleotides
opposite lesions in vitro, suggesting that a distinct polymerase
should act in this first step and that Pol zeta can efficiently extend
from primer-terminal base pairs containing mismatches or lesions
[6].
Rev1 encodes for a deoxycytidyl transferase that preferentially
incorporates C opposite to an abasic site [7]. Also, Rev1 interacts
in vitro with Pol zeta through a Rev3-Rev1 binding and this
interaction strongly stimulates the activity of Pol zeta and,
probably, contributes to its targeting to the replication fork [8].
Recently, it was found that Pol zeta and Rev1 localize in
mitochondria and that they participate in the mitochondrial DNA
mutagenesis, since disruption of REV3, REV7 or REV1 resulted in
a strongly decreased frequency of 21 frameshift mutations in
mtDNA [9]. On the contrary, it was shown that deletion of REV3,
REV7 or REV1 resulted in increased frequencies of both
spontaneous and UV-induced mitochondrial erythromycin resis-
tance, due to base substitutions [10]. On the basis of their results,
these authors speculated that, in absence of the TLS by Rev1 and/
or Pol zeta, the mitochondrial DNA polymerase gamma (Pol
gamma), the mitochondrial replicase, could create mutations in
efforts to bypass lesions that block the replication fork [10]. As a
consequence, Pol zeta and Rev1, which in the nucleus are
responsible with other DNA polymerases for the error-prone
bypass of DNA lesions, in the mitochondrial compartment
function in a less mutagenic pathway [10].
Pol gamma is a protein conserved in fungi and animals.
Structurally, human Pol gamma is a heterotrimer composed by
one catalytic subunit, encoded by POLG, and two accessory
subunits, encoded by POLG2 [11]. The catalytic subunit contains
an N-terminal 39-59 exonuclease domain (residues 170–440), a C-
terminal polymerase domain (residues 440–475 and 785–1239)
and a spacer region encompassing residues 475–785 [12]. To date,
more than 150 pathological mutations in POLG have been
identified in severe mitochondrial disorders (http://tools.niehs.
nih.gov/polg/) and, among them, a few mutations have been
recently described in stavudine induced toxicity [13,14], in
valproate induced hepatotoxicity [15,16] and in breast tumori-
genesis [17]. This places POLG as a major locus for mitochondrial
diseases and disorders.
In yeast the DNA polymerase gamma, encoded by MIP1 gene,
is composed by a sole catalytic subunit [18]. Thanks to the
similarity between human Pol gamma and Mip1 (approximately
43%), yeast has been used to validate the role of human putative
pathological mutations, to understand the biochemical conse-
quences associated to these mutations, to study the pharmacoge-
netics of drugs such as valproate and stavudine, and to find
mechanisms able to rescue the detrimental effects of Mip1
mutations [16,19–28]. Since a therapy has not been yet developed
for mitochondrial diseases caused by POLG mutations, a major
goal of the research involving yeast/animal models is to find new
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mutations.
Yeast is a suitable model organism to study the effects of nuclear
mutations affecting mtDNA stability, thanks to its ability to survive
in absence of a functional mitochondrial genome and to the
possibility to easily analyze mtDNA mutability. Yeast cells
containing deletions-carrying mtDNA, called rho-, or cells which
have completely lost mtDNA, called rho
0, are respiratory deficient
and produce colony of small size, called petite. rho
2 cells, which
arise more frequently than rho
0 cells, retain only small fragments of
wt mtDNA, from 30% to less than 1% (reviewed in [29]).
Although the mechanisms thanks to which rho
2 mutations arise
are not fully know, analysis of the regions flanking the deleted
regions suggest that mtDNA of some of these rho
2 cells derives
from recombination between direct repeats flanking the deleted
region with consequent excision [29]. In addition, deletions do not
occur randomly at all. As a matter of fact, some fragments,
encompassing COB, COX2 and COX3 genes, are most frequently
retained [29]. These large deletions make mtDNA irreversibly
unfunctional. In S. cerevisiae, petite mutants arise spontaneously with
high frequency (approximately 10
22) [29]. The frequency of petite
mutants is a measure of mtDNA extended mutability and is an
index of mtDNA instability. Extended mutability is indeed a series
of large deletions (generally .70%) that arise spontaneously, and
partially randomly, in the mtDNA, without involvement of point
mutations. Mutations in a large group of nuclear genes, encoding
for proteins directly or indirectly involved in mtDNA replication,
recombination, stability and maintenance (reviewed in [30])
produce increase of petite mutability. mtDNA point mutations
can be also easily measured as frequency of spontaneous mutants
resistant to erythromycin (Ery
R mutants), an antibiotic that inhibits
mitochondrial but not cytoplasmic translation. In fact, resistance
to erythromycin is acquired through specific transversions or
transitions in the mitochondrial gene encoding the 21 S rRNA, in
particular at 1950, 1951, 1952 and 3993 positions [31–34]. Ery
R
mutants arise spontaneously approximately at a frequency of
10
27–10
28. Ery
R mutability is influenced by replication fidelity of
DNA polymerase gamma as well as by the activity of some
enzymes involved in mtDNA repair and/or recombination [34–
37].
In an attempt to investigate about genetic conditions that might
reduce the damages caused by mutations in POLG, we analyzed
the effect of deletion or overexpression of TLS polymerases that,
together with DNA polymerase gamma, are present in mitochon-
dria, Pol zeta (Rev3–Rev7) and Rev1. Genetic tests based on gene
overexpression are widely used in yeast to assess a role of a gene
function in a biological process. Several researches are reported
where one or more proteins were overexpressed with this aim,
among which a study showing that overexpression of Rev3 led to
increasing UV-induced mutagenesis [38]. In addition, gene
overexpression is commonly used to rescue the phenotypic defects
caused by mutations in another gene which is functionally
associated. For example, in the case of MIP1, overexpression of
RNR1, encoding the large subunit of the ribonucleotide reductase,
lead to the discovery that increased levels of dNTP pools reduced
the extended mutability caused by mutations in Mip1 [19,26,39].
This finding has had impacted also in studies on human DNA
polymerase gamma pathological mutations [26], where, starting
from analysis in yeast, it has been shown that human DNA
polymerase gamma harboring the pathological mutation H932Y
has a ,200-fold reduced affinity to the incoming dNTPs.
Here we found that increased expression of Pol zeta resulted in
a significant reduction of extended mutability caused by mutations
mapping in different domains of MIP1 and that overexpression of
both Pol zeta and Rev1 led to a reduction in mtDNA point
mutability.
Materials and Methods
Yeast strains and media
The yeast strains used in this work are DWM-5A (Mata ade2-1
leu2-3,112 ura3-1 trp1-1 his3-11,15 can1-100 mip1::Kan
R), DYY-4C
(Mata ade2-1 leu2-3,112 ura3-1 trp1-1 his3-11,15 can1-100 mip1::-
Kan
R sml1::HIS3) [19], W303-1A CAN
S (Mata ade2-1 leu2-3,112
ura3-1 trp1-1 his3-11,15) (a kind gift from Antoni Barrientos,
University of Miami Miller School of Medicine, Miami, FL, USA),
W303-1B (Mata ade2-1 leu2-3,112 ura3-1 trp1-1 his3-11,15 can1-
100) [40], BY4742 rev1D (Mata, his3D1, leu2D0, lys2D0, ura3D0
rev1::Kan
R), BY4742 rev7D (Mata, his3D1, leu2D0, lys2D0, ura3D0
rev7::Kan
R) (Euroscarf collection), DWM-5Ar3 (Mata ade2-1 leu2-
3,112 ura3-1 trp1-1 his3-11,15 can1-100 mip1::Kan
R rev3::Hph
R),
DWM-9A (Mata ade2-1 leu2-3,112 ura3-1 trp1-1 his3-11,15 can1-
100 mip1::Hph
R) [41], DWM-9Ar1 (Mata ade2-1 leu2-3,112 ura3-1
trp1-1 his3-11,15 can1-100 mip1::Hph
R rev1::Kan
R), DWM-9Ar7
(Mata ade2-1 leu2-3,112 ura3-1 trp1-1 his3-11,15 can1-100
mip1::Hph
R rev7::Kan
R).
Synthetic defined medium (SD) contained 6.9 g/l yeast nitrogen
base without amino acids (Formedium), synthetic complete
medium (SC) was SD supplemented with 1 g/l drop out mix
[42]. YP medium contained 1% yeast extract (Formedium) and
2% peptone (Formedium), and YPA medium was YP supple-
mented with 40 mg/ml adenine base (Formedium). Carbon
sources were added as indicated in the text. YPAEG-Ery
contained 1% yeast extract (Difco), 2% Bacto-peptone (Difco),
40 mg/l adenine base, 25 mM potassium phosphate pH 6.5, 3%
ethanol, 3% glycerol and 3 g/l erythromycin (Sigma). CAN plates
was SD medium supplemented with 0.006% L-canavanine sulfate
(Sigma), amino acids and bases necessary to complement the
auxotrophy and 2% glucose.
Plasmids construction
The DNA constructions produced in this work were obtained
using plasmids pFL38, which is centromeric and brings the URA3
marker, pFL39 (centromeric, TRP1 marker) [43], YEplac195
(multicopy, URA3 marker), YEplac181 (multicopy, LEU2 marker)
[44], pUG35 (centromeric, URA3 marker, for EGFP fusion)
(http://mips.helmholtz-muenchen.de/proj/yeast/info/tools/
hegemann/gfp.html), pTL85 (multicopy, KanMX4 marker, for
EGFP fusion) [41] and pAG32, an integrative plasmid used as
template for gene disruption with the HphMX4 cassette [45].
Plasmids pFL38-MIP1 and pFL39 harboring wt or mutant mip1
alleles have been previously described [19]. YEplac195-REV3 was
obtained by PCR-amplification of REV3, including the upstream
and the downstream regions, from genomic DNA of strain DWM-
5A with primers REV3-Fw (gcgcgggtaccggatccaagaatccctgtgg) and
REV3-Rv (gcgccgaattccttagaggatacgaagattcc), digestion with KpnI
and EcoRI of both the PCR fragment and YEplac195 and ligation.
YEplac195-REV7 was obtained by PCR-amplification of REV7
from genomic DNA of strain DWM-5A with primers REV7-Fw
(gcgccgtcgacgatgaatgggaaaagaagtgc) and REV7-Rv (gcgcgggtacc-
catggaaccagacagaagacc), digestion of both the PCR fragment and
YEplac195 with SalI and KpnI and ligation. YEplac195-REV3/
REV7 was obtained by subcloning REV7 from YEplac195-REV7 to
YEplac195-REV3 digested with SalI and KpnI. YEplac181-REV1
was obtained by PCR amplification of REV1 from genomic DNA
of strain BY4742 with primers REV1-Fw (cggcgggtcgacgtgaagt-
gatcatgcacatcg) and REV1-Rv (cggccggtacccttacgcatttctactgttgg),
digestion of both the PCR fragment and YEplac181 with SalI and
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cation of REV3 ORF from genomic DNA of strain DWM-5A with
primers REV3GFPFw (ccgccgaattcatgtcgagggagtcgaacgacac) and
REV3GFPRv (ccgccgtcgacccaatcatttagagatattaatgc), digestion of
both the PCR fragment and pUG35 with EcoRI and SalI and
ligation in order to clone REV3 in frame with the EGFP gene.
pTL85-REV3 was obtained by subcloning REV3 from pUG35-
REV3 to pTL85 digested with XbaI and SalI. The REV3 DNA
region corresponding to the amino acid stretch 1 to 534 was
cloned in frame with the EGFP gene of pUG35 by amplification of
the fragment from genomic DNA of strain BY4742 with primers
REV3GFPFw and R3GFPRvS (ggcccgtcgaccagaatatcttgataaccg)
and cloning it between the EcoRI and SalI sites. All the cloned
fragments were sequenced to check for the absence of mutations.
REV3 mutagenesis
505–508 RKRKK stretch of Rev3 was mutagenized to AAAAA
through the overlap extension technique [46]. In the first set of
PCR reactions, the REV3 fragment encoding for the 1–534 Rev3
stretch was amplified with i) the primer REV3GFPFw and the
mutagenic primer REV3NONSRV (cgtaatcccgcagccataaccGCc-
GCtGCgGCcGCagacagcaacgatgttttattagc), and ii) the mutagenic
primer REV3NONSFW, complementary to REV3NONSRV,
and the R3GFPRVS primer. The final mutagenized product was
obtained by using the overlapping PCR fragments as template and
REV3NONSFW and R3GFPRVS as external primers. The
product was then digested with EcoRI and SalI and cloned in
EcoRI-SalI digested pUG35.
To mutagenize YEPlac195-REV3, a fragment of REV3 was
amplified with the primer REV3MUTFW (cattgagacaccaaa-
gatgtgc) and with the mutagenic primer REV3NONSRV, and
with the mutagenic primer REV3NONSFW and the primer
REV3MUTRV (cagaatggaaatctattcctatc). The final product was
obtained as above and was cloned in NgoMIV-SacI digested
YEplac195-REV3. The entire cloned fragment was sequenced to
confirm the presence of the mutations.
Disruption of REV3, REV7 and REV1
REV3 was disrupted in strain DWM-5A by using the HphMX4
cassette amplified from plasmid pAG32 [34] by using primers
DELREV3FW (gttcataaaacgctggaagtaaaaattagggcatcctttaaaaggC-
CTTGACAGTCTTGACGTGC) and DELREV3RV (aagtaatc-
gaatacatttttcaataatcttctgctgggctgggatCGCACTTAACTTCGCAT-
CTG), each of which contains a 59 stretch complementary to a
sequence internal to REV3 ORF and a 39 stretch, in uppercase,
complementary to the extremities of the HphMX4 cassette.
Disruptants were as resistant to 250 mg/ml hygromycin B. Correct
disruption was confirmed by PCR.
REV7 and REV1 were disrupted in strain DWM-5A9 by using
the KanMX4 cassette. The disrupted rev7::Kan
R and rev1::Kan
R loci
were amplified from strain BY4742 rev7D and BY4742 rev1D,
respectively, by using primers external to the loci: REV7-Fw and
REV7-Rv, or REV1-Fw and REV1-Rv. Disruptants were selected
on YP supplemented with 200 mg/ml geneticin and disruption was
confirmed by PCR.
Transformation of yeast strains
Yeast strains were transformed by lithium acetate methods [47].
We used the ‘‘Quick and easy method’’ (http://home.cc.
umanitoba.ca/,gietz/Quick.html) in case of transformation with
centromeric or episomal (multicopy) plasmids, and the ‘‘Best
Method’’ (http://home.cc.umanitoba.ca/,gietz/method.html) in
case of disruption cassettes.
Determination of mitochondrial and nuclear mutability
Petite frequency was determined as previously reported [48]. To
determine the effect of antioxidant agents on the extended
mtDNA mutability, wild-type and mutant strains, were grown
on liquid SCD medium supplemented with 40 mM dihydrolipoic
acid (Sigma) or 10 mM MitoQ (a kind gift from Luigi Palmieri,
University of Bari, Italy) for two 24-hour growth cycles.
Dihydrolipoic acid was supplemented from a 40 mM stock
solution in ethanol, while MitoQ was supplemented from a
5 mM stock solution in DMSO. Control experiment in which
equal amounts of ethanol (0.1%) or DMSO (0.2%) were added to
untreated cells was done in parallel. For each strain/condition at
least three independent experiments were performed on three
independent clones. Statistical analysis of petite frequency was
performed by a two-tailed t-test.
Ery
R mutant frequency was determined as previously reported
[48]. Briefly, 15 independent colonies, isolated on SC medium
supplemented with 2% glucose, were inoculated into 2 ml of SC
liquid medium supplemented with 2% ethanol and grown to
saturation (approximately 48 h). Cultures were then plated on
YPAEG-Ery medium and dilutions were plated nonselectively on
YP medium supplemented with 3% glycerol (300–500 colonies) for
a total cell count. After 7 days incubation, Ery
R mutant frequency
was determined by the method of the median [49]. Each
experiment was repeated at least three times on two independent
clones for each strain. Statistical analysis of Ery
R mutant frequency
was performed by a one-tailed t-test.
Nuclear point mutability was evaluated by measuring the
mutation rate of Can
R mutants in strain W303-1A CAN
S, bearing
the wt copy of CAN1, as previously reported [50], except that
colonies were grown on SC medium supplemented with 2%
glucose. Mutation rates were calculated using median values
according to Lea and Coulson [49] by using the program
FALCOR [51]. Rates are given as mean of four independent
experiments in each of which 10 independent colonies for each
clone were tested. Unpaired two-tailed t-test was used to evaluate
the statistical significance.
In every test, frequencies or rates were considered significantly
different when p,0.05.
Northern blot and semiquantitative RT-PCR
Total RNA was extracted from 10 ml of culture at a
concentration of 1 OD600/ml, according to [52]. For Northern
blot analysis, 25 mg of RNA were blotted according to [53]. The
probes for hybridization were obtained by purifying the 1 Kb
EcoRV fragment of REV3 and by amplifying REV7 with primers
REV7N-Fw (gggtagagaagtggctgagg) and REV7N-Rv (ctcgccctc-
ttcatattgag). Probes were labeled using [a-32P]dCTP and the kit
‘Rediprime II DNA Labelling System’ (GE Healthcare). Signals
were acquired after different time exposures with Kodak films or
with PhosphorImager and quantified by ImageQuant software
(Molecular Dynamics).
For RT-PCR, 1.5 mg of RNA were treated with DNase
(Invitrogen), precipitated and converted to cDNA with Proto-
ScriptH M-MuLV First Strand cDNA Synthesis Kit (NEB) by
using oligod(T). Semiquantitative PCR was performed by
amplifying a fragment of REV1 cDNA with primers REV1rtFW
(gtatattccagccgatcaaattcc) and REV1rtRV (cgtttggaagcctgaatgatcc)
and, as control, a fragment of TAF10 DNA with primers
FWTAF10 (atattccaggatcaggtcttccgtagc) and RVTAF10 (gtagtct-
tctcattctgttgatgttgttgttg). PCR samples were taken after 20, 23, 26,
29, 32 and 35 cycles, and aliquots of equal volume was loaded on a
0.8% agarose gel. Images were acquired by Kodak Digital Science
D120 zoom digital camera, converted to gray scale with Photo-
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(Molecular Dynamics). To avoid saturation, signals were consid-
ered only if the signal deriving from the PCR amplification with 3-
cycle less was 6–8-fold lower. Both in the case of Northern analysis
and in the case of RT-PCR, relative levels of mRNA were
quantified by comparison with a house-keeping gene signal (ACT1
or TAF10). All experiments were performed three times.
Fluorescence microscopy
Cells were grown in solid SC medium without methionine and
supplemented with 2% glucose. After 24 hours, cells were
resuspended in Tris–HCl 50 mM pH 7.5, incubated with 1 mg/
ml DAPI (49,6-diamidino-2-phenylindole) for 15 min on ice and
observed with a 1006magnification using DAPI or FITC filters.
Pictures were taken with constant parameters (100 ms exposure
for DAPI and 250–500 ms exposure for GFP with Nikon ACT-1
acquisition software) and processed to optimize contrast and
brightness with Adobe Photoshop 7.0.
Results
Pol zeta overexpression rescues the mtDNA mutability
induced by specific mip1 mutations
We have previously constructed a set of Saccharomyces
cerevisiae mip1 mutant alleles, corresponding to POLG pathological
mutations, and determined their effects on mtDNA extended and
point mutability (Table 1) [19–21,23]. These mutant alleles
localized in different Mip1 domains, displayed different in vivo
and in vitro defects and behaved either as dominant or recessive
(Table 1 and Figure 1).We analyzed the effect of overexpression
and deletion of Pol zeta and Rev1 on the mtDNA mutability
induced by these mip1 mutations, based on the recent finding that
these polymerases were found in mitochondria, where Pol zeta and
Mip1 belong to the same epistatic pathway [9].
REV3 and REV7 were cloned in the multicopy plasmid
YEplac195 and introduced i) in the strain DWM-5A (mip1D)
transformed with a number of recessive mip1 mutant alleles
(haploid condition) and ii) in the strain W303-1B (MIP1)
transformed with dominant mip1 mutant alleles (heteroallelic
condition). Extended mtDNA mutability was first determined in
these transformants by analyzing the frequency of spontaneous
petite mutants.
In presence of overexpressed REV3, the level of petite mutants
decreased; the rescue was mutation specific, being null for some
mutations and significant for other ones (Figure 2). The strongest
effect was observed for haploid strains bearing mutations G807R
(50% reduction) and A692T (25% reduction). The REV7
overexpression, on the contrary, had slighter effects, which
however were significant for mutations A692T and G807R
(Figure 2A). In heteroallelic strains harboring wt MIP1 and
dominant mip1
E698G, mip1
K749R or mip1
Y757C mutant alleles
(Figure 2B) no rescue was observed in the presence of either
REV3 or REV7.
We also evaluated the combined effects of REV3 and REV7
overexpression by cloning the two genes together in the
YEplac195 plasmid. Northern blot analysis indicated that REV3
and REV7 were expressed at high level (10–12 fold increase of
mRNA levels) when cloned either alone or together, demonstrat-
ing that their concomitant presence in the plasmid did not affect
the level of their expression (Figure 3A). Overexpression of whole
Pol zeta had the same effect than overexpression of Rev3
(Figure 2), suggesting that Rev3 alone was responsible of the
observed rescue or that the physiological levels of Rev7, which is
more abundant than Rev3 [54], were sufficient to ensure the
highest level of rescue. However the slight decrease in petite
frequency obtained overexpressing Rev7 alone suggests, as
demonstrated below, that also Rev7 participates to the rescue
and that the petite mutants’ reduction observed is most likely due to
a slight increase of the whole Pol zeta.
Effect of REV3 deletion on extended and point mtDNA
mutability
We next investigated the effect of REV3 deletion on mtDNA
stability. No difference was observed between REV3 and rev3D
regarding the frequency of petite mutants in strains harboring either
wt MIP1 allele or mutant mip1 alleles, indicating that the REV3
deletion produced no effect on extended mutability (data not
shown).
However, deletion of REV3 resulted in alteration of mtDNA
point mutation, with 2.5 fold increase of Ery
R mutant frequency
in the MIP1 wt strain, in agreement with results reported by
Kalifa and Sia [10] (Table 2). In addition, strains carrying
mip1
C261R, mip1
A692T and mip1
G807R mutant alleles showed a
further increase of Ery
R mutation (an increase of 3.9-, 3.3- and
5.1-fold, respectively) (Table 2), indicating that mutations in
MIP1 and deletion of REV3 have a synergistic effect in rising
point mutability. Furthermore, the ratios of Ery
R mutant
frequencies of rev3D strains to REV3 wt strains parallelized the
mutator phenotype of the mip1 mutant allele, being the lowest in
mip1
A692T strain showing a moderate increase of Ery
R frequency
compared to wt MIP1 strain (approximately 3.4-fold), and being
the highest in the strain mip1
G807R showing an increase of 8.8
times the Ery
R frequency of MIP1 strain (Table 2). Therefore,
Pol zeta is not physiologically involved in the maintenance of
full mtDNA but is required for the fidelity of the mtDNA
replication.
Effects of REV1 overexpression
Rev3 subunit of Pol zeta binds to Rev1, and the complex Pol
zeta-Rev1 increases the efficiency of translesion synthesis by Pol
zeta [8]. We tested whether overexpression of REV1, together
with overexpression of Pol zeta, could further reduce the petite
frequency due to mip1
C261R, mip1
A692T and mip1
G807R mutant
alleles. REV1 was cloned in the multicopy plasmid YEplac181
and introduced in strains overexpressing both REV3 and REV7
and carrying wt MIP1, mip1
C261R, mip1
A692T and mip1
G807R
mutant alleles. RT-PCR analysis confirmed that REV1 was 9–
1 3 - f o l do v e r e x p r e s s e di nt r a n s f o r m a n tc e l l s( F i g u r e3 B )a n dt h a t
REV3 and REV7 were overexpressed at the same levels (10–12
fold overexpression) as in strain not harboring YEplac181-REV1
(data not shown). Together with REV1, we overexpressed both
REV3 and REV7, and not REV3 alone, because it is known that
Rev1 can recruit Rev7 through a Rev3 independent Rev1-Rev7
binding thus depleting the levels of Rev7 [54]. REV1 overex-
pression did not alter the frequency of petite,b o t hi np r e s e n c ea n d
absence of overexpressed Pol zeta (Figure 4). This result indicates
that either the physiological levels of REV1 are sufficient for the
rescue by Pol zeta overexpressed or that Rev1 is not involved.
Moreover, we observed that overexpression of both Pol zeta and
Rev1, but not of either Pol zeta or Rev1 individually, resulted in
a significant reduction of the Ery
R mutant frequency, in
particular for the strain carrying the mutation G807R
(Table 3). The results described here are symmetrical to those
obtained previously by Kalifa and Sia [10], who showed an
increase in Ery
R mutant frequency when REV1, REV3 or REV7
were disrupted
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PLoS ONE | www.plosone.org 5 March 2012 | Volume 7 | Issue 3 | e34322Figure 2. Petite frequency of mip1 strains overexpressing REV3, REV7, or both. Petite frequency was measured as reported in Materials and
Methods on three independent clones for each strain. All values are means at least of three independent experiments. (A) Haploid mutant strains
harboring mip1 recessive mutant alleles. (B) Heteroallelic strains harboring MIP1 wt allele and mip1 dominant mutant alleles. For each mip1 allele,
*
indicates that the petite frequency is significantly lower (p,0.05) than that of strain transformed with the empty plasmid (YEplac195).
doi:10.1371/journal.pone.0034322.g002
Figure 1. Linear representation of human Polg and yeast Mip1 with the mutations used in this study. NTD-Exo=N-terminal domain- 39-
59 exonuclease domain. Pol=polymerase domain.
doi:10.1371/journal.pone.0034322.g001
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PLoS ONE | www.plosone.org 6 March 2012 | Volume 7 | Issue 3 | e34322Rescue of extended mutability by Rev3 overexpression is
Rev7 dependent and Rev1 independent
We tested whether the rescue by Rev3 overexpression was
dependent on the physiological levels of Rev7 and Rev1. The
deletion of REV1 or REV7 had no effect on petite mutability (data
not shown). However, the rescue of petite mutability in MIP1
mutants, exerted by overexpressed Rev3, occurred only when
Rev7 was present (Table 4), indicating that the whole Pol zeta
participated in the rescue. We furthermore observed that
overexpression of REV7 in a rev3D strain did not reduce petite
frequency both in wt MIP1 and in mip1 mutant strains (data not
shown), corroborating this hypothesis. Unlike Rev7, Rev1 was
dispensable (Table 4), thus supporting the hypothesis reported in
the previous paragraph that Rev1 did not participate in the rescue
of the extended mutability.
Combined action of REV3 overexpression and other
chemical and genetic rescues
We have shown previously that a decrease of reactive oxygen
species and/or an increase of the mitochondrial dNTP pool
reduced the mtDNA extended mutagenesis induced by patholog-
ical Pol gamma mutations in yeast [19]. Several mutations in
MIP1, but not all, were rescued, albeit at different extent, by
treatment with dihydrolipoic acid or with the mitochondrial
specific ROS scavenger MitoQ [21]. To know whether this effect
could be increased by REV3 overexpression the petite frequency
was measured either in haploid (Figure 5A) or in heteroallelic
strains (Figure 5B) treated with these molecules. We found that
there was a negative correlation between the rescue exerted by
ROS scavengers and the rescue caused by REV3 overexpression
(Figure 2 and Figure 5).
In fact, in haploid strains harboring A692T and G807R
mutations, whose effect was reduced by overexpression of Rev3,
no rescue was exerted by dihydrolipoic acid or MitoQ. In contrast,
ROS scavengers strongly mitigated the effect of mip1 mutations
E698G, K749R, Y757C, that are insensitive to Rev3 overexpres-
sion.
The only exception was mutation C261R, whose effect was
slightly rescued both by treatment with ROS scavengers and by
Rev3 overexpression (Fig. 2A and Fig. 5A). In this case, the
additive effect of Pol zeta overexpression and ROS scavengers
(data not shown) suggested that two different mechanisms were
involved in the reduction of petite mutability observed.
The second mechanism able to rescue the mip1 induced mtDNA
extended mutability is the increase of the dNTP pools. In S.
cerevisiae an increase of the dNTP pool was obtained either by
overexpressing RNR1 gene, which encodes the large subunit of the
ribonucleotide reductase or by deleting SML1 gene, which encodes
an inhibitor of the latter activity [55]. It has been shown that
overexpression of RNR1 or deletion of SML1, reduced the petite
frequency in strains harboring specific MIP1 mutations
[20,26,39,55].
To evaluate the relationship between the rescue exerted by
REV3 overexpression and the rescue exerted by increasing the
dNTP pools, we deleted SML1 in strains harboring mip1
C261R,
mip1
A692T and mip1
G807R mutant alleles, in presence of overex-
pressed REV3. We observed that, for every mutation studied, the
Table 2. Ery
R mutant frequency in wt and rev3D strains transformed with wt or mutant mip1 alleles.
Ery
R per 10
7 cells:
wt strain
Fold increase
mutant mip1/wt MIP1
Ery
R per 10
7 cells:
rev3D strain
Fold increase rev3D strain/wt
strain
MIP1 1.560.3 1.0 3.760.6 2.5
mip1
C261R 5.660.8 3.7
* 22.062.9 3.9
*
mip1
A692T 5.160.6 3.4
* 16.662.7 3.3
mip1
G807R 13.261.9 8.8
* 67.969.4 5.1
*
Ery
R mutant frequency in wt and rev3D strains transformed with wt or mutant mip1 alleles was determined as reported in Materials and Methods. ‘‘Fold increase mutant
mip1/wt MIP1’’ was obtained by dividing the Ery
R frequency related to each mip1 allele by the Ery
R frequency related to MIP1 wt allele. ‘‘Fold increase rev3D strain/wt
strain’’ was obtained by dividing, for each mip1 allele, the Ery
R frequency of rev3D strain by that of wt strain. * indicates that the fold increase is significantly higher
(p,0.05) than that of the MIP1 wt allele.
doi:10.1371/journal.pone.0034322.t002
Figure 3. mRNA levels in overexpressing strains. A. Northern blot mRNA expression of REV3 and REV7 in strains transformed with YEplac195
empty plasmid (1
st lane), YEplac195-REV3 (2
nd lane), YEplac195-REV7 (3
rd lane) and YEplac195-REV3/REV7 (4
th lane). Numbers indicate the fold increase
of REV3 and REV7 levels in overexpressing strains. mRNA of the ACT1 gene was used as a control. B. RT-PCR on REV1 in strains transformed with
YEplac81-REV1 and YEplac181 empty plasmid. cDNA of the TAF10 gene was used as control. Numbers over the gel indicate the number of PCR cycles,
number under the gel indicate the fold increase of REV1 levels in overexpressing strains.
doi:10.1371/journal.pone.0034322.g003
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PLoS ONE | www.plosone.org 7 March 2012 | Volume 7 | Issue 3 | e34322two processes act synergistically (Figure 6). For example, in strain
carrying mip1
A692T mutant allele the overexpression of REV3
reduced the petite frequency of approximately 1.3-fold, while
deletion of SML1 reduced the petite frequency of 4.4 fold: together,
the reduction was 9.1-fold. The synergistic effects were even
stronger in the case of strain harboring mip1
G807R mutation (1.9-
fold when REV3 was overexpressed, 4.1-fold when SML1 was
deleted, 15.7-fold together). It is likely that the observed synergy is
due to an increase of dNTP pools, which are the substrate for both
Mip1 and Pol zeta.
Construction of a mutant Rev3 which rescues mtDNA
mutability without affecting nuclear mutability
It was previously shown that in UV-treated cells, enhanced
expression of REV3 led to increase of nuclear point mutability,
measured as increase in the rate of arg4–17 reversion. Pol zeta
mutagenic function is dependent on Rev1 protein [38]. We
measured nuclear mutability in cells transformed with REV3 and/
or REV1 overexpressing plasmids to determine whether increased
levels of Pol zeta/Rev1 exerted mutagenic effect as a consequence
of a general mechanism associated to the translesion bypass. The
overexpression of Rev3 or Rev1 caused an approximately two-fold
increase of nuclear point mutability, measured as rate of Can
R
mutants. When both Pol zeta and Rev1 were overexpressed, the
rate of Can
R mutations increased approximately 3-fold (Figure 7).
Thus, overexpression of Pol zeta is useful to reduce the mtDNA
instability caused by specific mutations in MIP1 but is detrimental
to spontaneous nuclear mutability.
A Rev3 mutant which could enter into mitochondria, but not in
the nucleus is expected to reduce the mitochondrial mutability
without increasing nuclear mutability. To this end, we thought of
designing a REV3 gene whose product could not enter the nucleus.
We searched inside Rev3 for the potential nuclear localization
signal, by using the PredictNLS server (http://cubic.bioc.
columbia.edu/services/predictNLS/). Rev3 protein is predicted
to possess a unique bipartite nuclear localization signal encom-
passing amino acids 487–508 (Figure 8). Both upstream and
downstream basic amino acid stretches composing the bipartite
signal are critical for nuclear import [56].
To evaluate the localization of Rev3, we first cloned the whole
coding sequence either in a centromeric plasmid or in a multicopy
plasmid in frame with the EGFP gene. In both cases no GFP signal
was detected in transformant cells, as it was found previously in
high throughput analysis [57]. To overcome this problem, a
shorter Rev3 fragment encompassing residues 1–534, which
include the bipartite signal, was cloned in frame with EGFP. In
this case, in transformant cells we observed a fluorescent signal
corresponding to Rev3, localized in the nucleus. This was
confirmed by DAPI staining of mitochondrial and nuclear DNA
(Figure 6). Both in rho
+ strain, where DAPI stained both mtDNA
and nuclear DNA, and in the rho
0, where DAPI stained only
nuclear DNA, the GFP signal co-localized with the nuclear DAPI
signal.
To obtain a version of Rev3 unable to migrate in the nucleus,
we changed the 504–508 RKRKK downstream stretch to
AAAAA (Figure 8). When Rev3 fragment encompassing amino
acid 1–534 and harboring the 504–508 AAAAA stretch was fused
Figure 4. Petite frequency of mip1 mutant strains overexpressing Pol zeta, Rev1, or both. Petite frequency was measured as in Figure 2.
doi:10.1371/journal.pone.0034322.g004
Table 3. Ery
R mutant frequency in mip1 mutant strains overexpressing REV3, REV7 and/or REV1.
Empty plasmid- empty plasmid REV3/REV7- empty plasmid Empty plasmid-REV1 REV3/REV7-REV1
MIP1 1.460.2 1.360.3 1.660.3 1.060.3
mip1
C261R 4.960.7 4.460.7 4.260.4 1.960.2
*
mip1
A692T 4.360.5 4.560.6 4.760.6 2.360.3
*
mip1
G807R 16.762.1 15.261.8 16.463.7 6.561.1
*
Ery
R mutant frequency (per 10
7 cells) was determined as reported in Materials and Methods. For each mip1 strain,
*indicates that the Ery
R mutant frequency is significantly lower (p,0.05) than that of strain harboring both empty plasmids.
doi:10.1371/journal.pone.0034322.t003
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protein localized in the cytoplasm only (Figure 9). The AAAAA
mutation was then introduced in the full REV3 gene, cloned in the
multicopy plasmid YEplac195 and its effect was evaluated in
strains harboring mip1
A692T or mip1
G807R. In the presence of
overexpressed mutant Rev3, the mtDNA extended mutability
decreased at the same extent as achieved in the presence of
overexpressed wild type Rev3, indicating that the alteration of the
nuclear signal did not affect the ability of Rev3 of operating in
mitochondria (Table 5). If the mutated version of the enzyme did
not enter the nucleus, then it was expected that its overexpression
did not cause an increase in nuclear mutability. Indeed, in the
presence of overexpressed mutant Rev3 the nuclear point
mutability, measured as rate of Can
R mutants accumulation, did
not increase (Figure 7).
Discussion
In this study we showed that increased levels of Rev3, encoding
the catalytic subunit of Pol zeta, reduces both the mtDNA
extended mutability and the point mutability caused by specific
mutations in Mip1, the S. cerevisiae mtDNA polymerase. The rescue
of mtDNA extended mutability requires overexpression of the
catalytic subunit Rev3, but not that of the accessory subunit
encoded by REV7. However, a basal level of Rev7, which is known
to be expressed more than Rev3 [54], is necessary, because in a
rev7D strain the rescue does not occur.
Rev1, which interacts with Pol zeta for efficient bypass and
extension past the DNA lesion, is not required to rescue mtDNA
extended mutability, suggesting that Pol zeta can function
independently of Rev1 in mitochondrion. In contrast, Rev1
overexpression is necessary for the rescue of point mutability
mediated by Rev3. These observations suggest that the rescues
mediated by Rev3 overexpression are driven by two different
mechanisms: i. the rescue of mtDNA extended mutability
involving only Pol zeta and ii. the rescue of mtDNA point
mutability for which both Pol zeta and Rev1 are required. These
results are consistent with previous findings which indicate that the
instability of mitochondrial DNA in general is caused by
mechanisms different from those producing single point mutations
[19].
Deletion of REV3 did not influence the mtDNA extended
mutability (petite frequency), both in the wt strain and in mip1
mutant strains. In contrast, REV3 deletion caused an increase of
point mutability. Therefore Pol zeta, in mitochondria, functions in
a pathway less mutagenic than Mip1, supporting the hypothesis of
Kalifa and Sia [10]. Moreover, strains carrying mip1 mutant alleles
were themselves mutators, i.e. showed an Ery
R mutant frequency
higher than that of the wt strain. The observation that the higher
the mtDNA point mutability of the mutant strain, the higher the
effect of REV3 deletion, indicates that mutator Mip1 isoforms are
more sensitive to the absence of Rev3 than the wild type one and is
coherent with that hypothesis.
Table 4. Petite frequency in mip1 mutant strains deleted of REV1 or REV7 and overexpressing REV3 and REV7.
mip1
C261R mip1
A692T mip1
G807R
Empty plasmid REV3 REV3/REV7 Empty plasmid REV3 REV3/REV7 Empty plasmid REV3 REV3/REV7
rev1D 89.4 81.3
* 81.6
* 78.6 60.0
* 62.9
* 23.8 12.2
* 13.4
*
rev7D 91.5 89.4 82.7
* 79.2 80.2 57.3
* 24.0 24.6 13.1
*
Petite frequency was measured as reported in Figure 2. For each mip1 mutant rev1D or rev7D strain,
*indicates that the frequency is significantly different (p,0.05) compared to that of strain transformed with the YEplac195 empty plasmid.
doi:10.1371/journal.pone.0034322.t004
Figure 5. Petite frequency of mip1 strains treated with dihydrolipoic acid 40 mM (DHL) or 10 mM MitoQ. Petite frequency was measured
as reported in Materials and Methods on three independent clones for each strain at least twice. (A) Haploid mutant strains harboring mip1 recessive
mutant alleles. (B) Heteroallelic strains harboring MIP1 wt allele and mip1 dominant mutant alleles. For each mip1 strain, * indicates that the petite
frequency is significantly lower (p,0.05) than that of non-treated (NT) strain.
doi:10.1371/journal.pone.0034322.g005
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PLoS ONE | www.plosone.org 9 March 2012 | Volume 7 | Issue 3 | e34322Until now, it has not been yet elucidated the physiological role
of Pol zeta in mitochondria. Rev3, that is expressed at basal levels
during the whole vegetative cell cycle and only moderately (,2-
fold) overexpressed when cells are treated with UV, is expressed at
levels comparable or higher (,18-fold) than those obtained in this
study during the late phase of sporulation [58]. Interestingly,
Figure 6. Petite frequency of mip1
C261R, mip1
A692T and mip1
G807R strains disrupted in SML1 and overexpressing REV3. In each graph the
following petite frequencies are reported: mip1 strains transformed with YEplac195 empty plasmid (wt) or with YEPlac195-REV3 (REV3); mip1 sml1D
strains transformed with YEplac195 empty plasmid (sml1D) or with YEplac195-REV3 (sml1D/REV3 observed). In addition, the penultimate bar
represents the petite frequency of sml1D strain transformed with YEplac195-REV3 that would be expected if the effects of the overexpression of REV3
and of the deletion of SML1 were additive (sml1D/REV3 expected). * indicates that the observed frequency is significant lower than the expected one.
NS: not significant.
doi:10.1371/journal.pone.0034322.g006
Figure 7. Rate of Can
R mutants. Rate of Can
R mutants (A) in wt strains overexpressing REV3, REV7 and/or REV1 or (B) wt REV3 and mutant REV3,
encoding for the Rev3 protein harboring the 504–508 AAAAA stretch. Rate of Can
R mutants was measured as indicated in Materials and Methods on
three independent clones. If no stated differently, * indicates that the rate is significantly different from that of strain transformed with the empty
plasmid(s). NS: not significant.
doi:10.1371/journal.pone.0034322.g007
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PLoS ONE | www.plosone.org 10 March 2012 | Volume 7 | Issue 3 | e34322maintenance of a full non-mutated mtDNA genome is fundamen-
tal in meiosis, since respiratory-deficient diploid strains are unable
to sporulate or show increased levels of dead spores [59,60]. A
possible interpretation is that increased levels of Pol zeta could
have importance in the maintenance of wt mtDNA during
sporulation.
Regarding extended mutability, some MIP1 mutations equiva-
lent to human pathological mutations were rescued by overex-
pression of Rev3 while others were not. Y757C, E698G and
K749R, dominant mutations located in the polymerase domain,
together with the recessive mutation in the exonuclease domain
G259R, belong to this second group. These mutations are rescued
by treatment with antioxidant molecules such as dihydrolipoic acid
and MitoQ. Biochemical properties are available only for human
Y955C mutation, equivalent to yeast Y757C, that strongly reduces
the polymerase activity (,0.03% compared to the wild type), the
processivity and the nucleotide binding affinity, but does not affect
the DNA binding affinity [61,62]. It was previously reported also
that human Pol gamma harboring the Y955C mutation increases
the in vitro incorporation of 8-oxo-dGTP, the most abundant
oxidized nucleotide in mitochondria, and the translesion synthesis
opposite to an 8-oxo-dG residue [63]. The last observation
Figure 8. Position and sequence of the bipartite nuclear localization sequence. The stretch RKRKK was mutagenized to AAAAA to obtain a
mutant Rev3 fragment fused with EGFP for protein localization and a mutant Rev3 isoform for analysis of mtDNA mutability and nuclear point
mutability.
doi:10.1371/journal.pone.0034322.g008
Figure 9. Localization of Rev3. Localization of Rev3 and mutagen-
ized Rev3 fused with EGFP in (A) a rho
+ strain and in (B) a rho
0 strain.
Images have been acquired and adjusted as reported in Materials and
Methods. In rho
+ strain DAPI stains both the nuclear DNA (bigger spot)
and the mtDNA (small spots in the cell periphery). In rho
0 strain, which
is depleted of mtDNA, DAPI stains the nuclear DNA only.
doi:10.1371/journal.pone.0034322.g009
Table 5. Petite frequency in mip1 strains overexpressing REV3
or the mutagenized form of REV3.
Empty plasmid REV3 Mutant REV3
MIP1 2.460.3 2.060.2 2.260.2
mip1
A692T 80.464.3 60.264.1
* 63.263.6
*
mip1
G807R 23.562.4 12.661.4
* 11.661.7
*
Petite frequency was measured as reported in Figure 2. For each mip1 strain,
*indicates that the frequency is significantly different (p,0.05) compared to
that of strain transformed with the YEplac195 empty plasmid. The differences
between strains overexpressing wt REV3 or mutant REV3 are not significant.
doi:10.1371/journal.pone.0034322.t005
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PLoS ONE | www.plosone.org 11 March 2012 | Volume 7 | Issue 3 | e34322suggests that, although most of the mtDNA extended mutability by
Y757C mutation is caused by stalled replication due to strongly
reduced polymerase activity [61,62,64,65], the mtDNA damage
can be partially induced also by the accumulation of oxidized
bases. In addition, for heteroallelic strains containing dominant
mutations, it is possible that replication stalling by mutant Mip1
itself causes oxidative damage on mtDNA, which can partially
block replication by wt Mip1. Independently of the mechanisms, it
is known that there is a correlation between mtDNA extended
mutability and oxidative stress: petite frequency is higher in strains
with a reduced antioxidant potential [66], in strains treated with
hydrogen peroxide [67] and in strains deleted both in MSH1 and
in OGG1, encoding the mitochondrial glycosylase/lyase that
specifically excises 8-oxo-dG residues in mtDNA [68].
Differently from Y757C, E698G, K749R and G259R, muta-
tions C261R, R467W, A692T and G807R are rescued by Rev3
overexpression. These mutations are known to reduce the
polymerase activity and/or the processivity of Mip1 [20,27].
Yeast C261, equivalent to human S305, is part of a loop-helix
orienter module (amino acids 304–316) that creates steric
constraints leading to a destabilization of the template strand
and a modification in the arrangement of the primer strand [27]:
this subdomain in the 39–59 exonuclease plays a crucial role in the
DNA polymerase function with no major effect on the exonu-
cleolytic activity. yG807, equivalent to hG1051, is part of a
partitioning loop (amino acids 1050–1095) [12] that modulates the
partitioning of the primer strand between the polymerase and the
exonuclease active sites by forming stable contacts with correctly
base-paired primer-template DNA and destabilizing primer-
template DNA that contains mispairs [69] This subdomain is
adjacent to the orienter module, whose role is to position correctly
the partitioning loop. Mutations in the orienter loop and in the
partitioning loop both result in reduced DNA-binding affinity,
reduced polymerase activity, increased point mutability and
increased extended mutability [20,26,27]. yA692T, equivalent to
hA889, is part of a b-sheet which surrounds the catalytic residues
in the palm [12]. Mutations in this b-sheet are predicted to reduce
polymerase activity [69], and this effect was observed for A692T
mutation in yeast [26]. yR467, equivalent to hR574, is part of a
subdomain responsible for the intrinsic processivity of Pol gamma
[12]. As a matter of fact, mutation yR467W results in a decreased
processivity [27].
We showed that these recessive mutations with reduced
polymerase activity or processivity are insensitive to antioxidants
treatment. Thus, we speculate that different Pol gamma mutations
exert their negative effect according to two distinct ways. The first
one, rescued by the treatment with antioxidants, can be related to
the increased incorporation of 8-oxo-dG: in presence of antiox-
idant molecules the concentration of oxidized nucleotides and, as a
consequence, their incorporation in the mtDNA is reduced. The
inability of Pol zeta to rescue these Mip1 mutations may depend
partially on the low efficiency (approximately 12%) of Pol zeta to
incorporate nucleosides opposite to 8-oxo-dG [70,71]. The second
way, rescued by Rev3 overexpression, could be related to reduced
polymerase activity, processivity and/or TLS synthesis of mutated
mtDNA polymerase as in the case of C261R, R467W, A692T and
G807R mutations. Two modes of action may account for ability of
Rev3 to rescue this kind of mip1 mutations. i) Pol zeta could
participate directly to the replication of undamaged mtDNA at the
replicative fork partially playing the role of Mip1, as it was recently
demonstrated in the case of defective nuclear replisome due to
mutations in the replicative polymerases [72]. Interestingly, the
rescue is observed for mutations which cause reduced DNA
binding affinity (C261R) or for which reduced DNA binding
affinity is predicted (R467W and G807R) [27,69]. ii) Alternately,
Pol zeta could partially substitute mutant Mip1 defective of TLS,
either during the incorporation opposite to a lesion or the
extension from mismatched terminally nucleotides. Reports of
translesion synthesis by Pol gamma are limited. In vitro studies
showed that Pol gamma from higher eukaryotes is an enzyme with
a low TLS activity: it can bypass 8-oxo-dG incorporating dCMP
(,73%) or dAMP (,27%), but stalls the majority of the time
opposite abasic sites and opposite adducts containing benzo[a]py-
rene and benzo[c]phenantrene [73,74]. Moreover, it has been
recently reported that human Pol gamma barely bypasses
cyclobutane T-T dimers incorporating dAMP (,80%) or dCTP
(,20%), whereas it extends very inefficiently past the dimer [75].
These observations suggest that DNA polymerase gamma can
promote mutagenesis during TLS.
It is worthwhile mentioning that the Rev3 rescue was observed
only in the absence of wt Mip1. It could be possible that in
heteroallelic strains wt Mip1 out-competes even a 10-fold
overexpression of Pol zeta for the stalled replication that is caused
by mutant Mip1. As a consequence, putative beneficial effects of
overexpression of Pol zeta in heteroallelic strain could be hidden
by the presence of wt Mip1.
It has been demonstrated previously that mtDNA instability
caused by specific mutations in MIP1 is reduced by increasing the
dNTPs in the cell, either by overexpressing the RNR1 gene, which
encodes the large subunit of the ribonucleotide reductase, or by
deleting the SML1 gene, which encodes an inhibitor of the latter
activity [55]. Increased concentration of dNTPs is beneficial since
the basal levels of mitochondrial dNTP pools are a limiting factor
to maintain mtDNA copy number in yeast [76,77].
Here we describe that overexpression of Rev3 and increased
activity of ribonucleotide reductase have a synergistic effect on
reducing the frequency of petites. The synergistic effect is probably
due to the fact that the activity of Pol zeta but also of Mip1 have
improved with the increase of the dNTP pools, which are the
substrate of both DNA polymerases. In addition, the REV3
overexpressing sml1D strains harboring mip1 mutations A692T and
G807R reached petite frequency values which are slightly higher or
similar, respectively, to those of wt strain, thus indicating that
through genetic modifications it is possible to erase completely the
detrimental effects of such mip1 mutations on extended mutability.
It is worth mentioning that the human Pol zeta protein does not
localize to the mitochondria [9]. From the data here described, we
suggest that in mammalian cells carrying mutant Pol gamma a
beneficial effect could be obtained by overexpressing the yeast
Rev3 mutant isoform unable to enter the nucleus but capable of
rescuing mtDNA mutability, or as an alternative a mitochondrial
localizing version of human Rev3. It has been reported that
expression of a yeast mitochondrial repair/recombination enzyme,
Cce1, the cruciform-cutting endonuclease, in human cells
harboring partially duplicated mtDNA induced the appearance
of wt mtDNA, thus demonstrating that expression of a yeast
protein could be beneficial for mtDNA stability in mammalian
cells [78]. Such a genetic rescue could be associated to a treatment
with dNTPs, which seems to be beneficial for the detrimental
effects caused by specific mutations in human POLG: the
processivity defect of human DNA polymerase gamma harboring
Y955C mutation was overcome by increasing the dATP or dTTP
concentration during in vitro synthesis of mtDNA fragments [65]
and the treatment with dAMP and dGMP leads to a slight increase
in the levels of mtDNA in myoblasts deriving from an Alpers’
patient harboring mutations A467T and K1191N in POLG [79].
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